BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31077307)

  • 1. Lipidomics in Ulcerative Colitis Reveal Alteration in Mucosal Lipid Composition Associated With the Disease State.
    Diab J; Hansen T; Goll R; Stenlund H; Ahnlund M; Jensen E; Moritz T; Florholmen J; Forsdahl G
    Inflamm Bowel Dis; 2019 Oct; 25(11):1780-1787. PubMed ID: 31077307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naïve and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression.
    Diab J; Al-Mahdi R; Gouveia-Figueira S; Hansen T; Jensen E; Goll R; Moritz T; Florholmen J; Forsdahl G
    Inflamm Bowel Dis; 2019 Feb; 25(3):490-497. PubMed ID: 30476077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal and Plasma Metabolomes in New-onset Paediatric Inflammatory Bowel Disease: Correlations with Disease Characteristics and Plasma Inflammation Protein Markers.
    Nyström N; Prast-Nielsen S; Correia M; Globisch D; Engstrand L; Schuppe-Koistinen I; Halfvarson J
    J Crohns Colitis; 2023 Apr; 17(3):418-432. PubMed ID: 36219554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets.
    Bjerrum JT; Wang Y; Zhang J; Riis LB; Nielsen OH; Seidelin JB
    Int J Biol Sci; 2022; 18(5):1813-1828. PubMed ID: 35342362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology.
    Masoodi M; Pearl DS; Eiden M; Shute JK; Brown JF; Calder PC; Trebble TM
    PLoS One; 2013; 8(10):e76532. PubMed ID: 24204637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
    Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligoclonal T-cell Receptor Repertoire in Colonic Biopsies of Patients with Microscopic Colitis and Ulcerative Colitis.
    Günaltay S; Repsilber D; Helenius G; Nyhlin N; Bohr J; Hultgren O; Hultgren Hörnquist E
    Inflamm Bowel Dis; 2017 Jun; 23(6):932-945. PubMed ID: 28498152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imbalanced mucosal microcirculation in the remission stage of ulcerative colitis using probe-based confocal laser endomicroscopy.
    Tian Y; Zheng Y; Teng G; Li J; Wang H
    BMC Gastroenterol; 2019 Jul; 19(1):114. PubMed ID: 31262270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal Metabolomic Profiling and Pathway Analysis Reveal the Metabolic Signature of Ulcerative Colitis.
    Diab J; Hansen T; Goll R; Stenlund H; Jensen E; Moritz T; Florholmen J; Forsdahl G
    Metabolites; 2019 Nov; 9(12):. PubMed ID: 31783598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis.
    Braun A; Treede I; Gotthardt D; Tietje A; Zahn A; Ruhwald R; Schoenfeld U; Welsch T; Kienle P; Erben G; Lehmann WD; Fuellekrug J; Stremmel W; Ehehalt R
    Inflamm Bowel Dis; 2009 Nov; 15(11):1705-20. PubMed ID: 19504612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis.
    Lennon G; Balfe Á; Bambury N; Lavelle A; Maguire A; Docherty NG; Coffey JC; Winter DC; Sheahan K; O'Connell PR
    Colorectal Dis; 2014 May; 16(5):O161-9. PubMed ID: 24345279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipidomic studies revealing serological markers associated with the occurrence of retinopathy in type 2 diabetes.
    He M; Hou G; Liu M; Peng Z; Guo H; Wang Y; Sui J; Liu H; Yin X; Zhang M; Chen Z; Rensen PCN; Lin L; Wang Y; Shi B
    J Transl Med; 2024 May; 22(1):448. PubMed ID: 38741137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis.
    van der Post S; Jabbar KS; Birchenough G; Arike L; Akhtar N; Sjovall H; Johansson MEV; Hansson GC
    Gut; 2019 Dec; 68(12):2142-2151. PubMed ID: 30914450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations.
    Planell N; Lozano JJ; Mora-Buch R; Masamunt MC; Jimeno M; Ordás I; Esteller M; Ricart E; Piqué JM; Panés J; Salas A
    Gut; 2013 Jul; 62(7):967-76. PubMed ID: 23135761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confocal laser endomicroscopy: a new gold standard for the assessment of mucosal healing in ulcerative colitis.
    Macé V; Ahluwalia A; Coron E; Le Rhun M; Boureille A; Bossard C; Mosnier JF; Matysiak-Budnik T; Tarnawski AS
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():85-92. PubMed ID: 25827810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipidomic Profiling in Inflammatory Bowel Disease: Comparison Between Ulcerative Colitis and Crohn's Disease.
    Fan F; Mundra PA; Fang L; Galvin A; Moore XL; Weir JM; Wong G; White DA; Chin-Dusting J; Sparrow MP; Meikle PJ; Dart AM
    Inflamm Bowel Dis; 2015 Jul; 21(7):1511-8. PubMed ID: 25895111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
    Patel A; Panchal H; Dubinsky MC
    Inflamm Bowel Dis; 2017 Sep; 23(9):1600-1604. PubMed ID: 28590341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of endoscopic indices in the determination of disease activity in patients with ulcerative colitis.
    Kucharski M; Karczewski J; Mańkowska-Wierzbicka D; Karmelita-Katulska K; Grzymisławski M; Kaczmarek E; Iwanik K; Rzymski P; Swora-Cwynar E; Linke K; Dobrowolska A
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):722-30. PubMed ID: 26894632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Predictive Biomarkers of Relapse in Ulcerative Colitis: A Proteomics Approach.
    Assadsangabi A; Evans CA; Corfe BM; Lobo AJ
    Inflamm Bowel Dis; 2024 May; 30(5):808-819. PubMed ID: 37889841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyamine metabolism in colonic mucosa from patients with ulcerative colitis.
    Obayashi M; Matsui-Yuasa I; Matsumoto T; Kitano A; Kobayashi K; Otani S
    Am J Gastroenterol; 1992 Jun; 87(6):736-40. PubMed ID: 1590311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.